Ernest G. Therkorn

Array ( [id] => 8453742 [patent_doc_number] => 20120264688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'PROCESS FOR THE PURIFICATION OF RECOMBINANT HUMAN ERYTHROPOIETIN (EPO), EPO THUS PURIFIED AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME' [patent_app_type] => utility [patent_app_number] => 13/497500 [patent_app_country] => US [patent_app_date] => 2010-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11686 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8453740 [patent_doc_number] => 20120264687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'MODIFIED ERYTHROPOIETIN TO WHICH WATER-SOLUBLE LONG-CHAIN MOLECULE IS ADDED' [patent_app_type] => utility [patent_app_number] => 13/395534 [patent_app_country] => US [patent_app_date] => 2010-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8228 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13395534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335111 [patent_doc_number] => 20120201812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'STABLE FORMULATIONS OF POLYPEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/393679 [patent_app_country] => US [patent_app_date] => 2010-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 40300 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5953810 [patent_doc_number] => 20110034379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'Gastrin Compositions And Formulations, And Methods Of Use And Preparation' [patent_app_type] => utility [patent_app_number] => 12/843411 [patent_app_country] => US [patent_app_date] => 2010-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15960 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034379.pdf [firstpage_image] =>[orig_patent_app_number] => 12843411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7729136 [patent_doc_number] => 08101381 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Human cytokine receptor' [patent_app_type] => utility [patent_app_number] => 12/832882 [patent_app_country] => US [patent_app_date] => 2010-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 79518 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101381.pdf [firstpage_image] =>[orig_patent_app_number] => 12832882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8538341 [patent_doc_number] => 08314063 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-20 [patent_title] => 'Pharmaceutical formulations' [patent_app_type] => utility [patent_app_number] => 12/829325 [patent_app_country] => US [patent_app_date] => 2010-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13213 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12829325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6387605 [patent_doc_number] => 20100317585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'LONG-ACTING COAGULATION FACTORS AND METHODS OF PRODUCING SAME' [patent_app_type] => utility [patent_app_number] => 12/826754 [patent_app_country] => US [patent_app_date] => 2010-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23467 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317585.pdf [firstpage_image] =>[orig_patent_app_number] => 12826754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8211165 [patent_doc_number] => 20120129770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'NOVEL POLYNUCLEOTIDE MOLECULES FOR ENHANCED GENE EXPRESSION' [patent_app_type] => utility [patent_app_number] => 13/380394 [patent_app_country] => US [patent_app_date] => 2010-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9091 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20120129770.pdf [firstpage_image] =>[orig_patent_app_number] => 13380394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8278422 [patent_doc_number] => 20120172295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'GIP RECEPTOR-ACTIVE GLUCAGON COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/378001 [patent_app_country] => US [patent_app_date] => 2010-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 75333 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13378001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8446282 [patent_doc_number] => 08288334 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-16 [patent_title] => 'Peptides for wound healing' [patent_app_type] => utility [patent_app_number] => 12/814691 [patent_app_country] => US [patent_app_date] => 2010-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6975 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12814691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6644186 [patent_doc_number] => 20100227821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'MONITORING AND MODULATING HGF/HGFR ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/784272 [patent_app_country] => US [patent_app_date] => 2010-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19949 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227821.pdf [firstpage_image] =>[orig_patent_app_number] => 12784272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024278 [patent_doc_number] => 20110052604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'Human Anti-OPGL Neutralizing Antibodies as Selective OPGL Pathway Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/782376 [patent_app_country] => US [patent_app_date] => 2010-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 26405 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052604.pdf [firstpage_image] =>[orig_patent_app_number] => 12782376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6486816 [patent_doc_number] => 20100285527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Novel Polypeptide, cDNA Encoding the Same, and Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/772617 [patent_app_country] => US [patent_app_date] => 2010-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10592 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285527.pdf [firstpage_image] =>[orig_patent_app_number] => 12772617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6479157 [patent_doc_number] => 20100285137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'ANTIBIOTIC/BONE MORPHOGENIC PROTEIN FORMULATION AND METHOD OF TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/758605 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16840 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285137.pdf [firstpage_image] =>[orig_patent_app_number] => 12758605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6270938 [patent_doc_number] => 20100255014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'Protein Complex Using An Immunoglobulin Fragment and Method For The Preparation Thereof' [patent_app_type] => utility [patent_app_number] => 12/757635 [patent_app_country] => US [patent_app_date] => 2010-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19408 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20100255014.pdf [firstpage_image] =>[orig_patent_app_number] => 12757635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5993473 [patent_doc_number] => 20110015126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'Compositions and Methods For Inducing Apoptosis In Tumor Cells' [patent_app_type] => utility [patent_app_number] => 12/721659 [patent_app_country] => US [patent_app_date] => 2010-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 11974 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015126.pdf [firstpage_image] =>[orig_patent_app_number] => 12721659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6504542 [patent_doc_number] => 20100260781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'TREATMENT METHODS FOR AUTOIMMUNE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/720845 [patent_app_country] => US [patent_app_date] => 2010-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22722 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260781.pdf [firstpage_image] =>[orig_patent_app_number] => 12720845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650833 [patent_doc_number] => 20110300102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'COMPOSITION FOR SKIN REGENERATION, CONTAINING A SECRETION IN THE CULTURE OF AN EMBRYONIC STEM CELL-DERIVED ENDOTHELIAL PROGENITOR CELL OR FRACTIONS THEREOF, AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/202309 [patent_app_country] => US [patent_app_date] => 2010-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5811 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300102.pdf [firstpage_image] =>[orig_patent_app_number] => 13202309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6511511 [patent_doc_number] => 20100210815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'Insulin production methods and pro-insulin constructs' [patent_app_type] => utility [patent_app_number] => 12/658852 [patent_app_country] => US [patent_app_date] => 2010-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8585 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210815.pdf [firstpage_image] =>[orig_patent_app_number] => 12658852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7784670 [patent_doc_number] => 20120046226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'Combined Treatment of Multiple Sclerosis' [patent_app_type] => utility [patent_app_number] => 13/148626 [patent_app_country] => US [patent_app_date] => 2010-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9695 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046226.pdf [firstpage_image] =>[orig_patent_app_number] => 13148626 [rel_patent_id] =>[rel_patent_doc_number] =>)